# antimicrobial resistance (blogs) — RSS Amplifier Recent posts from the 2 feeds in the RSS Amplifier directory that cover antimicrobial resistance. Page: Feed: --- ## [From discussion to discovery: meet INCATE’s new Stage I ventures](https://www.incate.net/from-discussion-to-discovery-meet-incates-new-stage-i-ventures/) _2026-05-19 · HP · INCATE_ For the first time, INCATE’s Selection Committee didn’t simply meet — they came together in person at the headquarters of one of our industry partners, creating an atmosphere in Munich filled with energy, curiosity, and a shared commitment to innovation. What began as a session to evaluate new ventures quickly evolved into something much bigger: \[...\] The post From discussion to discovery: meet… ## [Editor-in-Chief’s Note](https://nbph.iedcr.gov.bd/editor-in-chiefs-note-15/) _2026-05-14 · iedcr\_nbph · nbph_ Prof. Mamunar Rashid This issue presents four articles: three detailing active surveillance programs at the Institute of Epidemiology, Disease Control and Research (IEDCR), and a fourth investigating antimicrobial utilization in… ## [Evaluation of Acute Encephalitis Syndrome Surveillance in Bangladesh, 2023](https://nbph.iedcr.gov.bd/evaluation-of-acute-encephalitis-syndrome-surveillance-in-bangladesh-2023/) _2026-05-14 · iedcr\_nbph · nbph_ This study evaluated the Acute Encephalitis Syndrome (AES) surveillance system in Bangladesh for 2022 using the CDC 2001 guidelines to assess system attributes and overall usefulness. A cross-sectional evaluation was conducted between April and September 2023 across three purposively ## [Antibiotic usage pattern in Upazila (sub-district) chicken farms of Bangladesh, 2017-2018](https://nbph.iedcr.gov.bd/antibiotic-usage-pattern-in-upazila-sub-district-chicken-farms-of-bangladesh-2017-2018/) _2026-05-14 · iedcr\_nbph · nbph_ The Department of Livestock Services (DLS) in Bangladesh has been conducting surveillance to monitor antibiotic usage in poultry farming and assess antimicrobial resistance (AMR) at the Upazila Level. Surveillance data collected between 2017 to 2018 by the Department of Livestock Services (DLS) across ## [Nipah virus detection in a previously unaffected region of Bangladesh, 2019: Implications for surveillance](https://nbph.iedcr.gov.bd/nipah-virus-detection-in-a-previously-unaffected-region-of-bangladesh-2019-implications-for-surveillance/) _2026-05-14 · iedcr\_nbph · nbph_ Nipah virus (NiV) infection is a highly fatal emerging zoonotic disease transmitting from bats to humans and can cause further human-to-human transmission. The incubation period for Nipah virus is typically 4-14 days after exposure, but can range ## [Working System of the National Influenza Surveillance, Bangladesh](https://nbph.iedcr.gov.bd/working-system-of-the-national-influenza-surveillance-bangladesh/) _2026-05-14 · iedcr\_nbph · nbph_ Influenza is a contagious respiratory illness caused by influenza viruses. It infects the nose, throat, and lungs commonly known as flu. The influenza has various types and sub-types infecting both… ## [Building momentum: recent milestones at Obulytix](https://www.incate.net/building-momentum-recent-milestones-at-obulytix/) _2026-04-28 · HP · INCATE_ Obulytix has had an exciting start to the year, marked by important milestones and strengthening the contribution to the fight against antimicrobial resistance. Obulytix joined the END2AMR consortium, a new Innovative Health Initiative (IHI)-supported collaboration focused on accelerating solutions against drug-resistant bacterial infections through cross-sector innovation. Most recently,… ## [Big ideas, bold solutions: inside the 10th AMR Conference](https://www.incate.net/big-ideas-bold-solutions-inside-the-10th-amr-conference/) _2026-03-16 · HP · INCATE_ The 10th AMR Conference in Basel once again brought together some of the most passionate minds in antimicrobial research, policy, and innovation. This year’s edition was particularly energizing, not only because of the scientific progress shared, but also because of the growing sense of momentum across the entire AMR community. A powerful start: tackling \[...\] The post Big ideas, bold solutions:… ## [Bovine Tuberculosis in Artificially Inseminated Bulls in Selected Farms of Bangladesh, 2019](https://nbph.iedcr.gov.bd/bovine-tuberculosis-in-artificially-inseminated-bulls-in-selected-farms-of-bangladesh-2019/) _2026-03-04 · iedcr\_nbph · nbph_ Bovine tuberculosis (bTB) is an infectious bacterial disease in cattle, primarily caused by Mycobacterium bovis, a species within the M. tuberculosis complex. bTB hinders the milk, meat, and semen production in livestock with worldwide annual ## [One Health Initiatives in Barishal: Experiences from Advancing Antimicrobial Resistance Surveillance and Zoonotic Disease Research at the Regional Level](https://nbph.iedcr.gov.bd/one-health-initiatives-in-barishal-experiences-from-advancing-antimicrobial-resistance-surveillance-and-zoonotic-disease-research-at-the-regional-level/) _2026-03-04 · iedcr\_nbph · nbph_ The One Health approach—an integrated framework that links human, animal, and environmental health—is increasingly recognized as a crucial strategy for addressing complex and interconnected public health threats such as antimicrobial resistance ## [Meet Claude, an AI assistant (Sponsored)](https://crawlproof.com/a/jx9z3SbPOXVn) _2026-03-04 · **Sponsored**_ Chat with Claude at claude.ai — a conversational AI assistant. ## [A Summary Report of the National Influenza Surveillance Bangladesh (NISB) – 2015 to 2021](https://nbph.iedcr.gov.bd/a-summary-report-of-the-national-influenza-surveillance-bangladesh-nisb-2015-to-2021/) _2026-03-04 · iedcr\_nbph · nbph_ Influenza represents a critical public health challenge in Bangladesh, characterized by its potential for seasonal outbreaks and significant morbidity, particularly among vulnerable populations such as children and individuals with pre-existing health conditions. ## [National Antimicrobial Resistance (AMR) Surveillance in Bangladesh](https://nbph.iedcr.gov.bd/national-antimicrobial-resistance-amr-surveillance-in-bangladesh/) _2026-03-04 · iedcr\_nbph · nbph_ According to Global Action Plan of the World Health Organization, Surveillance is one of the main strategies for AMR containment. Since 2016, the National Antimicrobial Resistance (AMR) Surveillance in Bangladesh is initiated by the Institute of ## [INCATE and Cystic Fibrosis Foundation Collaborate to Combat Antimicrobial Resistance](https://www.incate.net/incate-and-cystic-fibrosis-foundation-collaborate-to-combat-antimicrobial-resistance/) _2026-02-26 · HP · INCATE_ February 26, 2026— INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early-stage anti-infective innovation, today announced a collaboration with the Cystic Fibrosis Foundation to advance research, innovation, and solutions addressing antimicrobial resistance (AMR). People living with cystic fibrosis (CF) are particularly vulnerable… ## [Introducing new Stage I ventures](https://www.incate.net/introducing-new-stage-i-ventures/) _2026-02-12 · HP · INCATE_ The INCATE Selection Committee has selected five promising ventures to receive Stage I support. Want to find out who they are? Explore the latest additions and learn more about the innovative ideas moving forward in the INCATE program. Inicure AB - I-CURE: Small molecule FPR1 agonists treat and cure resistant bacterial infections by boosting the \[...\] The post Introducing new Stage I ventures… ## [INCATE appoints first Chief Executive Officer to shape its future vision](https://www.incate.net/incate-ceo/) _2026-02-03 · HP · INCATE_ February 3, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, today announced a defining milestone in its institutional journey with the appointment of Holger Zimmermann as its first Chief Executive Officer. Holger Zimmermann brings extensive experience in industrial research, biotechnology… ## [The Finalists for the Startup Pitch Event 2026 are in!](https://www.incate.net/finalists-sup2026/) _2026-01-20 · HP · INCATE_ Every year, selecting the finalists for the Startup Pitch Event becomes more challenging, and 2026 was no exception. The level of creativity, ambition, and innovation we saw this year was truly impressive. A huge thank-you to everyone who submitted a pitch: you made the decision incredibly tough! We’re excited to welcome the finalists to the \[...\] The post The Finalists for the Startup Pitch Event… ## [JPMA and INCATE join forces to Advance Innovation in the Fight Against Antimicrobial Resistance](https://www.incate.net/jpma-and-incate-join-forces-to-advance-innovation-in-the-fight-against-antimicrobial-resistance/) _2026-01-20 · HP · INCATE_ January 21, 2026 – The Japan Pharmaceutical Manufacturers Association (JPMA) has joined forces with INCATE (INCubator for Antimicrobial Therapies in Europe), strengthening global collaboration to support innovation and solutions against antimicrobial resistance (AMR). INCATE brings together academic research, industry, investors, and public sector organizations to support early-stage innovators… ## [Basilea joins INCATE to support antifungal innovation](https://www.incate.net/basilea-joins-incate-to-support-antifungal-innovation/) _2026-01-13 · HP · INCATE_ January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced today a partnership with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections. Basilea is joining… ## [2025: the year in review — progress, proof, and purpose](https://www.incate.net/2025-the-year-in-review-progress-proof-and-purpose/) _2025-12-19 · HP · INCATE_ Just before turning the page to 2026, it’s worth pausing to reflect on both the progress made and the challenges that remain in the fight against antimicrobial resistance (AMR). The numbers, unfortunately, haven’t changed. According to The Lancet, up to 39 million lives could be lost to antibiotic-resistant infections by 2050 if we fail to \[...\] The post 2025: the year in review — progress, proof,…